US Stock MarketDetailed Quotes

MDGED MEDIGENE AG

Watchlist
  • 2.590
  • 0.0000.00%
15min DelayClose Aug 29 09:30 ET
38.17MMarket Cap-2.06P/E (TTM)

MEDIGENE AG Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(Q4)Dec 31, 2019
(Q3)Sep 30, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations
-77.00%-16.59M
8.84%-9.37M
63.80%-10.28M
-42.60%-28.4M
---19.92M
----
----
Other non cash items
-58.33%115K
-20.46%276K
-4.93%347K
25.00%365K
--292K
----
----
Change In working capital
66.44%-297K
81.10%-885K
-63.68%-4.68M
-296.23%-2.86M
--1.46M
----
----
-Change in receivables
212.45%2.57M
-349.56%-2.28M
-65.52%914K
677.42%2.65M
--341K
----
----
-Change in inventory
----
----
----
----
--305K
----
----
-Change in other current liabilities
-303.97%-2.57M
122.24%1.26M
-23.81%-5.66M
-673.78%-4.57M
--797K
----
----
Cash from discontinued investing activities
Operating cash flow
-226.24%-15.12M
211.36%11.98M
56.61%-10.75M
-50.92%-24.79M
---16.42M
---7.1M
---4.09M
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale
35.36%-616K
-935.87%-953K
80.00%-92K
67.79%-460K
---1.43M
----
----
Net intangibles purchase and sale
--0
---52K
--0
0.00%1M
--1M
----
----
Net investment purchase and sale
127.27%3M
-367.12%-11M
-79.99%4.12M
-16.34%20.58M
--24.59M
----
----
Net other investing changes
----
----
----
--2K
----
----
----
Cash from discontinued investing activities
Investing cash flow
119.86%2.38M
-398.19%-12.01M
-80.94%4.03M
-12.61%21.12M
--24.17M
--22.06M
---43K
Financing cash flow
Cash flow from continuing financing activities
Net issuance payments of debt
----
----
----
----
--756K
----
----
Net common stock issuance
----
----
----
----
--21K
----
----
Cash from discontinued financing activities
Financing cash flow
-175.18%-776K
72.70%-282K
-25.06%-1.03M
-76.12%-826K
---469K
--1.21M
---606K
Net cash flow
Beginning cash position
-0.86%22.22M
-25.36%22.42M
-13.40%30.03M
26.54%34.68M
--27.41M
----
----
Current changes in cash
-4,244.37%-13.51M
95.99%-311K
-72.70%-7.76M
-161.78%-4.49M
--7.27M
----
----
Effect of exchange rate changes
-133.05%-39K
-18.06%118K
192.90%144K
---155K
--0
----
----
End cash Position
-60.97%8.67M
-0.86%22.22M
-25.36%22.42M
-13.40%30.03M
--34.68M
----
----
Free cash flow
-243.89%-15.78M
200.83%10.97M
56.95%-10.88M
-41.56%-25.27M
---17.85M
---8.53M
---2.98M
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(Q4)Dec 31, 2019(Q3)Sep 30, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations -77.00%-16.59M8.84%-9.37M63.80%-10.28M-42.60%-28.4M---19.92M--------
Other non cash items -58.33%115K-20.46%276K-4.93%347K25.00%365K--292K--------
Change In working capital 66.44%-297K81.10%-885K-63.68%-4.68M-296.23%-2.86M--1.46M--------
-Change in receivables 212.45%2.57M-349.56%-2.28M-65.52%914K677.42%2.65M--341K--------
-Change in inventory ------------------305K--------
-Change in other current liabilities -303.97%-2.57M122.24%1.26M-23.81%-5.66M-673.78%-4.57M--797K--------
Cash from discontinued investing activities
Operating cash flow -226.24%-15.12M211.36%11.98M56.61%-10.75M-50.92%-24.79M---16.42M---7.1M---4.09M
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale 35.36%-616K-935.87%-953K80.00%-92K67.79%-460K---1.43M--------
Net intangibles purchase and sale --0---52K--00.00%1M--1M--------
Net investment purchase and sale 127.27%3M-367.12%-11M-79.99%4.12M-16.34%20.58M--24.59M--------
Net other investing changes --------------2K------------
Cash from discontinued investing activities
Investing cash flow 119.86%2.38M-398.19%-12.01M-80.94%4.03M-12.61%21.12M--24.17M--22.06M---43K
Financing cash flow
Cash flow from continuing financing activities
Net issuance payments of debt ------------------756K--------
Net common stock issuance ------------------21K--------
Cash from discontinued financing activities
Financing cash flow -175.18%-776K72.70%-282K-25.06%-1.03M-76.12%-826K---469K--1.21M---606K
Net cash flow
Beginning cash position -0.86%22.22M-25.36%22.42M-13.40%30.03M26.54%34.68M--27.41M--------
Current changes in cash -4,244.37%-13.51M95.99%-311K-72.70%-7.76M-161.78%-4.49M--7.27M--------
Effect of exchange rate changes -133.05%-39K-18.06%118K192.90%144K---155K--0--------
End cash Position -60.97%8.67M-0.86%22.22M-25.36%22.42M-13.40%30.03M--34.68M--------
Free cash flow -243.89%-15.78M200.83%10.97M56.95%-10.88M-41.56%-25.27M---17.85M---8.53M---2.98M
Currency Unit EUREUREUREUREUREUREUR
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.